ResMed Inc. (NYSE:RMD) Q4 2024 Earnings Call Transcript August 1, 2024
ResMed Inc. beats earnings expectations. Reported EPS is $2.08, expectations were $2.07.
Operator: Hello, and welcome to the Q4 Fiscal Year 2024 ResMed Earnings Conference Call. My name is Kevin, and I’ll be your operator for today’s call. [Operator Instructions] Please note this conference call is being recorded. I’ll now turn the call over to Amy Wakeham, Chief Investor Relations Officer. Please go ahead, Amy.
Amy...
